Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04064463 · ClinicalTrials.gov registry record · NA
Dual Reinforcement Contingency Management for Alcohol Use Disorders
A NA study of Alcohol Use Disorder and Contingency Management, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT04064463 is a NA study of Alcohol Use Disorder and Contingency Management that has completed, run by UConn Health. The registered enrollment target is 74 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04064463, a NA study of Alcohol Use Disorder and Contingency Management, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
Phosphatidylethanol (PEth) is a direct biomarker of alcohol that can detect moderate to heavy drinking with high sensitivity and specificity over 3-week periods. Reinforcing negative PEth results alongside attendance may increase the proportion of participants who respond to CM during and post treatment. In the proposed study, the investigators will collect PEth samples every 3 weeks for 12 weeks in 150 participants initiating outpatient treatment for alcohol use disorders. Using a two-group randomized design, participants will be assigned to standard care with PEth monitoring alone or with CM for attending treatment and submitting PEth negative samples. Compared to standard care and monitoring, the investigators expect that the CM intervention will result in greater attendance, more PEth negative samples, and higher proportions of self-reported non-drinking days, along with lower proportions of heavy drinking days, over the short term and the long term, measured throughout a 12-month follow-up. The investigators anticipate that the reinforcement intervention may decrease other drug use and sexual risk behaviors that spread HIV, reduce psychiatric symptoms, and improve quality of life as well.
Conditions Studied
Interventions
- BEHAVIORAL Contingency management
- BEHAVIORAL Standard care
Study Locations (1)
Connecticut
- The Village - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2025-11-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04064463
The ClinicalTrials.gov registry entry for NCT04064463 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (77% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Contingency management is the first listed.
NCT04064463 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04064463 about?
NCT04064463 is a clinical study titled "Dual Reinforcement Contingency Management for Alcohol Use Disorders". Phosphatidylethanol (PEth) is a direct biomarker of alcohol that can detect moderate to heavy drinking with high sensitivity and specificity over 3-week periods. Reinforcing negative PEth results alongside attendance may increase the proportion of participants who respond to CM during and post treat...
What is the current status of trial NCT04064463?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2020-01-22. Estimated completion is 2025-11-25.
What conditions does trial NCT04064463 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Contingency Management.
What interventions are being tested in trial NCT04064463?
The interventions under investigation include: Contingency management (BEHAVIORAL), Standard care (BEHAVIORAL).
Who is sponsoring clinical trial NCT04064463?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04064463 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.